Results 291 to 300 of about 333,750 (340)

Enhancing Anti‐Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression

open access: yesAdvanced Science, EarlyView.
CD19‐293‐EV can switch the CD19 endocytosis pathway from clathrin‐mediated endocytosis to aggregation‐dependent endocytosis, leading to lysosomal degradation of the CD19/EVs complex. Degradation of the EVs leads to impairment in the IFN response and enhancement in EV uptake by target cells, creating a potent feedback cycle.
Zixuan Huang   +17 more
wiley   +1 more source

Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch. [PDF]

open access: yesPLoS One
Cao R   +8 more
europepmc   +1 more source

Use of FK 506 in the treatment of liver allograft rejection [PDF]

open access: yes, 1991
Bronsther, O   +14 more
core  

Acute rejection in donation after circulatory death (DCD) heart transplants. [PDF]

open access: yesJ Heart Lung Transplant
Li SS   +8 more
europepmc   +1 more source

Disulfiram, an Anti-alcoholic Drug, Targets Macrophages and Attenuates Acute Rejection in Rat Lung Allografts. [PDF]

open access: yesTranspl Int
Yoshiyasu N   +9 more
europepmc   +1 more source

Cardiac magnetic resonance assessment of acute rejection and cardiac allograft vasculopathy in pediatric heart transplant. [PDF]

open access: yesJ Heart Lung Transplant
Kikano S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy